article thumbnail

AbbVie announces its new CEO

European Pharmaceutical Review

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

article thumbnail

Lung cancer deaths decline but.

World of DTC Marketing

But it’s still the leading cause of cancer deaths. Moreover, localized lung cance r diagnoses rose to 28% in 2018 from 20% in 2013— the year that the U.S. Although lung cancer’s mortality rate has fallen, the disease is still the leading cause of cancer deaths. American Cancer Society’s ACS ).

Insurance 271
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma R&D productivity dips, but efficiency gains give hope

Clarivate

Figure 1 illustrates the trend in the number of NMEs first launched onto the world market between 2013 and 2022. In fact, the number of NMEs has grown by 65% between 2013 and 2022. Looking at NMEs launched globally in 2022 paints a gloomy picture at first sight, with a 28% drop from 2021 to 2022.

Pharma 52
article thumbnail

Neglected tropical diseases: non-profits lead the way as private sectors lags

Pharmaceutical Technology

Four countries managed to get rid of river blindness after adopting elimination strategies, with the first being Colombia in 2013. The post Neglected tropical diseases: non-profits lead the way as private sectors lags appeared first on Pharmaceutical Technology. DNDi has four treatments in the pipeline that target the adult worm.

Leads 64
article thumbnail

HCP’s use of social media: the good and the not so good

World of DTC Marketing

HCPs are also connecting more than ever: one study showed that HCP posts about healthcare increased from 10% in 2013 to 50% in 2019. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug. 33 Even now, nearly 70% of all HCPs are digital natives.

Media 294
article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

household income from 2009 to 2013 was $53,046, according to the United States Census Bureau, but many of the most recently approved anticancer treatments approved by the United States Food and Drug Administration (FDA) are priced well above $100,000 per year. .” This leads to a question; “where does it end?”

Pharma 210
article thumbnail

Antibiotics ‘no longer effective’ for childhood infections, finds study

European Pharmaceutical Review

The most recent guide was published by the WHO in 2013. The study, which was funded by the Wellcome Trust, also reveals the urgent need for global antibiotic guidelines to be updated, to reflect the rapidly evolving rates of AMR. The WHO has declared AMR as one of the top 10 global public health threats facing humanity.